Literature DB >> 14658841

Protection of mice against experimental Japanese encephalitis virus infections by neutralizing anti-glycoprotein E monoclonal antibodies.

A K Gupta1, V J Lad, A A Koshy.   

Abstract

Neutralizing monoclonal antibodies (MAbs) to glycoprotein E (gpE) of Japanese encephalitis (JE) virus given intraperitoneally (i.p.) (0.1 ml of immune ascitic fluid (AF) diluted 1:10 per mouse) to about 4-week-old Swiss mice 1 day prior or 2 days after the virus challenge (100 LD50 of JE virus administered intracerebrally (i.c.)) resulted in a decreased mortality along with an increased survival of the animals as demonstrated by the HAI-positive virus-specific (Hs) MAbs. The protective effect produced by four Hs MAbs was maximum when given 1 day prior the virus challenge, while other, namely HAI-positive flavivirus cross-reactive (Hx) and HAI-negative virus-specific (NHs) MAbs did not produce any effect. Interestingly, one of the two NHs MAbs, namely NHs-1 showed a reduced survival of mice given the MAb 2 days after the virus challenge. Administration of combinations of two or more Hs MAbs may be recommended due to their possible enhanced protection against JE virus infections in mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14658841

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  7 in total

1.  Pivotal role of antibody and subsidiary contribution of CD8+ T cells to recovery from infection in a murine model of Japanese encephalitis.

Authors:  Maximilian Larena; Matthias Regner; Eva Lee; Mario Lobigs
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

2.  CD8+ T cells complement antibodies in protecting against yellow fever virus.

Authors:  Maria R Bassi; Michael Kongsgaard; Maria A Steffensen; Christina Fenger; Michael Rasmussen; Karsten Skjødt; Bente Finsen; Anette Stryhn; Søren Buus; Jan P Christensen; Allan R Thomsen
Journal:  J Immunol       Date:  2014-12-24       Impact factor: 5.422

Review 3.  Preventive strategies for frequent outbreaks of Japanese encephalitis in Northern India.

Authors:  Vandana Saxena; Tapan N Dhole
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

4.  A preliminary randomized double blind placebo-controlled trial of intravenous immunoglobulin for Japanese encephalitis in Nepal.

Authors:  Ajit Rayamajhi; Sam Nightingale; Nisha Keshary Bhatta; Rupa Singh; Rachel Kneen; Elizabeth Ledger; Krishna Prasad Bista; Penny Lewthwaite; Chandeshwar Mahaseth; Lance Turtle; Jaimie Sue Robinson; Sareen Elizabeth Galbraith; Malgorzata Wnek; Barbara Wilmot Johnson; Brian Faragher; Michael John Griffiths; Tom Solomon
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

5.  Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in Mice.

Authors:  Albert To; Liana O Medina; Kenji O Mfuh; Michael M Lieberman; Teri Ann S Wong; Madhuri Namekar; Eileen Nakano; Chih-Yun Lai; Mukesh Kumar; Vivek R Nerurkar; Axel T Lehrer
Journal:  mSphere       Date:  2018-01-10       Impact factor: 4.389

Review 6.  Japanese encephalitis: the virus and vaccines.

Authors:  Sang-Im Yun; Young-Min Lee
Journal:  Hum Vaccin Immunother       Date:  2013-10-25       Impact factor: 3.452

7.  A new pharmacokinetic model for 90Y-ibritumomab tiuxetan based on 3-dimensional dosimetry.

Authors:  F Morschhauser; B Dekyndt; C Baillet; C Barthélémy; E Malek; J Fulcrand; P Bigot; D Huglo; B Décaudin; N Simon; P Odou
Journal:  Sci Rep       Date:  2018-10-05       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.